Adaptive Biotechnologies Corp (ADPT) USD0.0001

Sell:$17.75Buy:$17.78Price increased$0.40 (2.30%)

NASDAQ:Price decreased1.29%
Market closed |
Prices delayed by at least 15 minutes
Sell:$17.75
Buy:$17.78
Change:Price increased$0.40 (2.30%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$17.75
Buy:$17.78
Change:Price increased$0.40 (2.30%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 June 2026
Harlan S RobinsPresident
Sell
Regular sell transaction (market)
6,160$18.01$110,941.601,405,898
15 June 2026
Harlan S RobinsPresident
Sell
Regular sell transaction (market)
100,000$17.37$1,737,000.001,412,058
11 June 2026
Susan BobulskyChief Level Officer
Sell
Regular sell transaction (market)
5,000$19.00$95,000.00411,775
4 June 2026
Susan BobulskyChief Level Officer
Sell
Regular sell transaction (market)
11,000$18.00$198,000.00416,775
4 June 2026
Francis LoGroup Director
Sell
Regular sell transaction (market)
39,741$17.49$695,070.09250,934
18 May 2026
Kyle PiskelCFO
Sell
Tax related
3,115$13.04$40,619.60256,725
27 April 2026
Julie RubinsteinPresident/COO
Sell
Option/Award related
19,037$14.23$270,896.51377,802
24 April 2026
Julie RubinsteinPresident/COO
Sell
Regular sell transaction (market)
19,060$14.02$267,221.20382,132
23 April 2026
Julie RubinsteinPresident/COO
Sell
Option/Award related
19,060$13.74$261,884.40386,470
22 April 2026
Julie RubinsteinPresident/COO
Sell
Option/Award related
19,060$14.13$269,317.80390,808

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
21 November 2025
Sharon BenzenoChief Level Officer
Sell
Option/Award related
308,477$16.91$5,216,346.07296,791
20 November 2025
Sharon BenzenoChief Level Officer
Sell
Regular sell transaction (market)
297,925$16.54$4,927,679.50296,791
2 March 2026
Chad M RobinsChairman/CEO
Sell
Regular sell transaction (market)
289,024$15.82$4,572,359.681,987,330
11 March 2026
Chad M RobinsChairman/CEO
Sell
Tax related
329,600$13.17$4,340,832.002,301,113
11 March 2026
Harlan S RobinsPresident
Sell
Tax related
329,600$13.17$4,340,832.001,522,058

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.